Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-12-01T05:04:08.223Z Has data issue: false hasContentIssue false
  • English
  • Français

Control of Occupational Hepatitis B Among Healthcare Workers in the Czech Republic, 1982 to 1995

Published online by Cambridge University Press:  02 January 2015

Jaroslav Helcl ,
Jitka Cástková ,
Cestmir Benes ,
Lenka Novotna ,
Kent A Sepkowitz  and
Jack A. DeHovitz
Jaroslav Helcl
Affiliation:
National Institute of Public Health, Prague, Czech Republic
Jitka Cástková
Affiliation:
National Institute of Public Health, Prague, Czech Republic
Cestmir Benes
Affiliation:
National Institute of Public Health, Prague, Czech Republic
Lenka Novotna
Affiliation:
National Institute of Public Health, Prague, Czech Republic
Kent A Sepkowitz*
Affiliation:
Memorial Sloan-Kettering Cancer Center, New York City, New York
Jack A. DeHovitz
Affiliation:
Department of Preventive Medicine, SUNY Health Science Center at Brooklyn, New York
*
Infectious Disease Service, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Box 288, New York, NY 10021
Get access Rights & Permissions [Opens in a new window]

Abstract

Occupational hepatitis B remains a threat to healthcare workers (HCWs) worldwide, even with availability of an effective vaccine. Despite limited resources for public health, the Czech Republic instituted a mandatory vaccination program for HCWs in 1983. Annual incidence rates of acute hepatitis B were followed prospectively through 1995. Despite giving vaccine intradermally from 1983 to 1989 and intramuscularly as half dose from 1990 to 1995, rates of occupational hepatitis B decreased dramatically, from 177 cases per 100,000 workers in 1982 (before program initiated) to 17 cases per 100,000 in 1995. Among high-risk workers, the effect was even more dramatic (from 587 to 23 per 100,000). We conclude that strong public-health leadership led to control of occupational hepatitis B among HCWs in the Czech Republic, despite limited resources that precluded administering full-dose intramuscular vaccine for much of the program. Application of a similar program should be considered for other countries in regions that currently do not have a hepatitis B vaccination program.

Type
The International Perspective
Information
Infection Control & Hospital Epidemiology , Volume 21 , Issue 5 , May 2000 , pp. 343 - 346
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Centers for Disease Control. Protection against viral hepatitis: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1990;39(RR-2):1–26.Google Scholar
2. Lewis, TL, Alter, HJ, Chalmers, TC, Holland, PV, Purcell, RH, Alling, DW, et al. A comparison of the frequency of hepatitis-B antigen and antibody in hospital and nonhospital personnel. N Engl J Med 1973;289:647–651.Google Scholar
3. West, DJ. The risk of hepatitis B infection among health professionals in the United States: a review. Am J Med Sci 1984;287:26–33.Google Scholar
4. Osterholm, MT, Garayalde, SM. Clinical viral hepatitis B among Minnesota hospital personnel. JAMA 1985;254:3207–3212.Google Scholar
5. Gibas, A, Blewett, Dr, Schoenfeld, DA, Dienstag, JL. Prevalence and incidence of viral hepatitis in health workers in the prehepatitis B vaccination era. Am J Epidemiol 1992;136:603–610.CrossRefGoogle ScholarPubMed
6. Sepkowitz, KA. Occupationally acquired infections in health care workers, part II. Ann Intern Med 1996;125:917–928.Google Scholar
7. Occupational exposure to bloodborne pathogens—OSHA final rule. Fed Regist 1991;56:64004–64182.Google Scholar
8. Shapiro, CN. Occupational risk of infection with hepatitis B and hepatitis C virus. Surg Clin North Am 1995;75:1047–1056.Google Scholar
9. Agerton, TB, Mahoney, FJ, Polish, LB, Shapiro, CN. Impact of the Bloodborne Pathogens Standard on vaccination of healthcare workers with hepatitis B vaccine. Infect Control Hosp Epidemiol 1995;16:287–291.CrossRefGoogle ScholarPubMed
10. Mahoney, FJ, Stewart, K, Hu, H, Coleman, P, Alter, MJ. Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States. Arch Intern Med 1997;157:2601–2605.Google Scholar
11. Louther, J, Rivera, P, Villa, N, Feldman, J, DeHovitz, JH, Sepkowitz, KA. Hepatitis B vaccination program at a New York City hospital: seroprevalence, seroconversion, and declination. Am J Infect Control 1998;26:423–327.Google Scholar
12. Opatrný, K, Farník, J, Jindra, J, Valenta, J, Janda, J, Petera, V, et al. Virová hepatitis na hemodialyzðním stredisku. Prakt Lék 1978;58:753–756.Google Scholar
13. Markvart, K, Lobkovic, F, Vlasimská, H, Pecenková, I. [Antibodies against the superficial component of hepatitis B virus of health care workers]. Cesk Epidemiol Mikrobiol Imunol 1978;27:327–334. Czech.Google Scholar
14. Farnik, J, Topolcan, O, Karlícek, V, Honzikova, J, Miada, L, Beranova, I, et al. [HBS antigen and antibodies in health care workers]. Cas Lék Ces 1982;121:343–346. Czech.Google Scholar
15. Seycková, J, Helcl, J, Walter, G. Prevalence of viral hepatitis among the hospital staff in CST between 1980 and 1982. J Hyg Epid (Praha) 1984;28:267–278.Google Scholar
16. Centers for Disease Control and Prevention. Inadequate immune response among public safety workers receiving intradermal vaccination against hepatitis B—United States, 1990-1991. MMWR 1991;40:569–572.Google Scholar
17. Lanphear, BP, Linnemann, CC, Cannon, CG, DeRonde, MM. Decline of clinical hepatitis B in workers at a general hospital: relation to increasing vaccine-induced immunity. Clin Infed Dis 1993;16:10–14.Google Scholar
18. Alter, MJ, Hadler, SC, Margolis, HS, Alexander, WJ, Hu, FY, Judson, FN, et al. The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA 1990;263:1218–1222.Google Scholar
19. Sikorska, K, Laniec, M, Buraczewska, A, Hlebowicz, M, Keller, A, Majewska, K [Iatrogenic hepatitis B, non-Anon-B, and C virus infections acquired in health service institutions of the Gdansk province in 19861995]. Przegl Epidemiol 1997;51:229–237. Polish.Google Scholar
20. Narendranathan, M, Philip, M. Reusable needles—a major risk factor for acute virus B hepatitis. Trop Dod 1993;23:64–66.Google Scholar